Janney Montgomery Scott’s Dr. Reddy's Laboratories RDY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-63,080
Closed -$925K – 2780
2024
Q1
$925K Buy
63,080
+3,630
+6% +$53K ﹤0.01% 1571
2023
Q4
$827K Sell
59,450
-3,300
-5% -$44.1K ﹤0.01% 1560
2023
Q3
$839K Buy
62,750
+1,070
+2% +$14.5K ﹤0.01% 1435
2023
Q2
$779K Buy
61,680
+17,140
+38% +$200K ﹤0.01% 1568
2023
Q1
$507K Buy
+44,540
New +$481K ﹤0.01% 1721

Other funds holding RDY

Janney Montgomery Scott's RDY Position: Q2 2024 in Review

Janney Montgomery Scott sold out of Dr. Reddy's Laboratories (RDY) in Q2 2024, closing a stake of 63,080 shares — an estimated $925K sold.

Janney Montgomery Scott first reported a position in RDY in Q1 2023 and held it in 5 quarters. The position peaked at $925K in Q1 2024. 222 funds tracked by Wall St. Rank hold RDY as of Q2 2024.

  • Janney Montgomery Scott reported no remaining Dr. Reddy's Laboratories position as of Q2 2024 after selling out during the quarter.
  • Janney Montgomery Scott sold 63,080 Dr. Reddy's Laboratories shares in Q2 2024, an estimated $925K.
  • Janney Montgomery Scott first reported a position in Dr. Reddy's Laboratories in Q1 2023 and held it in 5 quarters.
  • Janney Montgomery Scott's Dr. Reddy's Laboratories position peaked at $925K in Q1 2024.
  • 222 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2024.

Based on Janney Montgomery Scott's 13F filing for Q2 2024, filed 25 Jul 2024.